John S Sampalis
Overview
Explore the profile of John S Sampalis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enright K, Sampalis J, Andriessen A, Nikolis A
Plast Surg (Oakv)
. 2024 Nov;
:22925503241249757.
PMID: 39553530
Research in aesthetic medicine commonly includes evaluations of subject satisfaction with treatment results. However, conventional analytic methods typically generate statistically imprecise ordinal scores. To overcome this limitation, researchers have begun...
2.
Haraoui B, Khraishi M, Choquette D, Fortin I, Kinch C, Galos C, et al.
Rheumatol Ther
. 2024 Nov;
11(6):1629-1648.
PMID: 39485671
Introduction: ORAL Surveillance, a post-authorisation safety study of patients with rheumatoid arthritis (RA) enriched for cardiovascular (CV) risk, demonstrated increased risk of major adverse CV events (MACE) and malignancies (excluding...
3.
Chandran V, Bessette L, Thorne C, Sheriff M, Rahman P, Gladman D, et al.
Rheumatol Ther
. 2024 Feb;
11(2):443-455.
PMID: 38416391
Introduction: The APPRAISE study was conducted to better understand the 12-month effectiveness, tolerability, and patient satisfaction with apremilast treatment for patients with psoriatic arthritis (PsA) in real-world settings. Methods: APPRAISE...
4.
Nikolis A, Enright K, Berros P, Sampalis J
J Cosmet Dermatol
. 2023 Jul;
22(9):2382-2390.
PMID: 37424173
Background: Hollowing of the infraorbital region represents a common concern among aesthetic patients. In the past decade, an increasing number of patients have resorted to noninvasive aesthetic procedures to treat...
5.
Haraoui B, Khraishi M, Choquette D, Lisnevskaia L, Teo M, Kinch C, et al.
Arthritis Care Res (Hoboken)
. 2022 Jun;
75(2):240-251.
PMID: 35678771
Objective: The Canadian Tofacitinib for Rheumatoid Arthritis Observational (CANTORAL) is the first Canadian prospective, observational study assessing tofacitinib. The objective was to assess effectiveness and safety for moderate to severe...
6.
Keystone E, Movahedi M, Cesta A, Bombardier C, Sampalis J, Rampakakis E
Clin Exp Rheumatol
. 2022 Apr;
40(11):2147-2152.
PMID: 35383561
Objectives: The Clinical Disease Activity Index (CDAI) is routinely used in clinical care when treating-to-target RA patients. Previous validation studies have looked at CDAI's overall performance; this analysis aimed at...
7.
Antoniou J, Silotch C, Epure L, Antoniou A, Sampalis J
J Arthroplasty
. 2022 Mar;
37(7S):S524-S529.
PMID: 35241321
Background: The aim of this study is to assess the independent effect of age on the risk of postsurgical complications and death in patients undergoing total hip arthroplasty (THA). Methods:...
8.
Fitzcharles M, Rampakakis E, Sampalis J, Shir Y, Cohen M, Starr M, et al.
Clin Exp Rheumatol
. 2021 May;
39 Suppl 130(3):115-119.
PMID: 33938797
Objectives: Medications have only small to moderate effects on symptoms in fibromyalgia (FM). Cannabinoids, including medical cannabis (MC) may have potential to fill this gap. Since recreational legalisation of cannabis...
9.
Hepworth E, Movahedi M, Rampakakis E, Mirza R, Lau A, Cesta A, et al.
Curr Rheumatol Rev
. 2020 Dec;
17(3):349-359.
PMID: 33308132
Objective: For patients with Rheumatoid Arthritis (RA) who do not achieve adequate clinical response with combined conventional synthetic disease-modifying anti-rheumatic drugs (cs- DMARDs), initiation of advanced therapies such as biologic...
10.
Zeiadin N, Rampakakis E, Turcotte E, Senta H, Sampalis J, Thorne C
Rheumatology (Oxford)
. 2020 Nov;
60(5):2434-2439.
PMID: 33221911
Background: Yttrium-90 (90Y) is approved in several countries as a radiosynoviorthesis agent in the intra-articular treatment of synovitis, however, no such radiopharmaceuticals are approved in Canada. The aim of this...